Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $176,628 - $226,462
2,020 New
2,020 $224,000
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $540,437 - $676,967
-7,477 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $535,951 - $589,411
7,477 New
7,477 $566,000
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $5.72 Million - $6.32 Million
-81,291 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $292,655 - $344,717
-4,250 Reduced 4.97%
81,291 $6.32 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $17,224 - $19,116
-240 Reduced 0.28%
85,541 $7.05 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $455,033 - $515,783
6,218 Added 7.82%
85,781 $7.17 Million
Q2 2020

Jul 31, 2020

SELL
$70.42 - $80.13 $26,407 - $30,048
-375 Reduced 0.47%
79,563 $6.2 Million
Q1 2020

May 13, 2020

SELL
$63.36 - $87.82 $15,206 - $21,076
-240 Reduced 0.3%
79,938 $6.2 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $3.64 Million - $3.97 Million
47,882 Added 148.26%
80,178 $6.79 Million
Q2 2019

Jul 26, 2019

SELL
$69.84 - $81.59 $2.38 Million - $2.78 Million
-34,117 Reduced 51.37%
32,296 $2.73 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $228,339 - $264,985
-3,500 Reduced 5.01%
66,413 $4.84 Million
Q3 2018

Oct 24, 2018

BUY
$57.69 - $67.84 $195,972 - $230,452
3,397 Added 5.11%
69,913 $4.99 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $762,450 - $895,800
15,000 Added 29.12%
66,516 $4.07 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $16,816 - $19,545
-330 Reduced 0.64%
51,516 $2.83 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $3.04 Million - $3.27 Million
51,846
51,846 $3.34 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Arch Point Investors Portfolio

Follow Arch Point Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

News

Stay updated on Arch Point Investors with notifications on news.